Rivaroxaban for Scheduled Work-up of DVT – The Ri-Schedule Study
Condition(s):Deep Venous ThrombosisLast Updated:January 23, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Deep Venous ThrombosisLast Updated:January 23, 2019Completed
Condition(s):Venous ThrombosisLast Updated:February 27, 2014Completed
Condition(s):Immature Platelets; Deep Venous ThrombosisLast Updated:August 13, 2018Completed
Condition(s):Deep Vein ThrombosisLast Updated:August 1, 2023Active, not recruiting
Condition(s):Deep Venous Thrombosis of Leg; Deep Vein ThrombosisLast Updated:January 30, 2023Withdrawn
Condition(s):Venous Thrombosis; Deep Vein ThrombosisLast Updated:November 18, 2015Completed
Condition(s):Deep Vein ThrombosisLast Updated:January 9, 2018Terminated
Condition(s):Deep Venous ThrombosisLast Updated:August 2, 2019Completed
Condition(s):Deep Venous Thromboses; Deep Venous Thrombosis of Left Leg; Deep Venous Thrombosis of Right Leg; Deep Venous Thrombosis ProximalLast Updated:February 1, 2017Completed
Condition(s):Venous Thrombosis; PregnancyLast Updated:December 9, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.